Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from July 2020.
generic drugs
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Topics include challenges with false negative tests for SARS-CoV-2 infection and difficulties in implementing and enforcing state opioid prescribing laws.
-
Read more: To Cut Prescription Drug Spending, Stop Delays for Generic Competition To Cut Prescription Drug Spending, Stop Delays for Generic Competition
While generic competition is crucial for reducing drug prices, brand-name drug manufacturers can utilize several strategies to delay such competition.
